SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Regulatory & Safety

News in brief

Sun Pharma pulls chemotherapy made at Gujarat plant

By Gareth MacDonald+

03-Jul-2014
Last updated on 03-Jul-2014 at 13:26 GMT

Indian drugmaker Sun Pharmaceutical has recalled 200 vials of the cancer drug gemcitabine in the US over concerns about its sterility.

According to a report by the US Food and Drug Administration (FDA ) tests conducted on a different batch of the drug made at the same plant in Gujarat, India detected a “particle excursion” raised questions about the sterility of the recalled vials.

The withdrawal was initiated on April 9 by Sun’s unit Caraco Pharmaceutical Laboratories.

Sun Pharma declined to comment when contacted by in-Pharmatechnologist.com.

Subscribe to our FREE newsletter

Get FREE access to authoritative breaking news, videos, podcasts, webinars and white papers. SUBSCRIBE

Key Industry Events

 

Access all events listing

Our events, Events from partners...